Haema AG is active in the field of blood plasma and whole blood collection and operates a number of donation centres in Germany. Haema is mainly collecting plasma for fractionation and further manufacture into plasma-derived medicinal products. Haema is further collecting whole blood and other blood components such as leukopaks as well as blood-derived products as raw materials for research and development as well as diagnostic purposes.

Haema is partner of the Grifols group. Grifols is a pharmaceutical and biotherapeutics group that develops, manufactures, and distributes plasma-derived medicinal products for the treatment of blood and immune diseases. Human plasma for fractiona-tion is a key raw material for Grifols.